EXECUTION COPY INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014 Page Schedule A-Schedule of Key Holders INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of March, 2014, by and among Oncobiologics, Inc., a New Jersey corporation (the “Company”), Strides Pharma Inc., a company incorporated under the laws of New Jersey (the “Investor”), and each of the shareholders listed on Schedule A hereto, each of whom is referred to herein as a “Key Holder”.
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014Investors’ Rights Agreement • May 11th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 11th, 2016 Company Industry JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of March, 2014, by and among Oncobiologics, Inc., a New Jersey corporation (the “Company”), Strides Pharma Inc., a company incorporated under the laws of New Jersey (the “Investor”), and each of the shareholders listed on Schedule A hereto, each of whom is referred to herein as a “Key Holder”.
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014Investors’ Rights Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 27th, 2016 Company Industry JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of March, 2014, by and among Oncobiologics, Inc., a New Jersey corporation (the “Company”), Strides Pharma Inc., a company incorporated under the laws of New Jersey (the “Investor”), and each of the shareholders listed on Schedule A hereto, each of whom is referred to herein as a “Key Holder”.
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014Investors’ Rights Agreement • December 18th, 2015 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 18th, 2015 Company Industry JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of March, 2014, by and among Oncobiologics, Inc., a New Jersey corporation (the “Company”), Strides Pharma Inc., a company incorporated under the laws of New Jersey (the “Investor”), and each of the shareholders listed on Schedule A hereto, each of whom is referred to herein as a “Key Holder”.